Becton Dickinson and Co (BDX) - Product Pipeline Analysis, 2017 Update

Summary

Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infectionsand cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Becton Dickinson and Co
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Becton Dickinson and Co Company Overview 7
Becton Dickinson and Co Company Snapshot 7
Becton Dickinson and Co Pipeline Products and Ongoing Clinical Trials Overview 7
Becton Dickinson and Co Pipeline Analysis Overview 10
Business Description 10
Becton Dickinson and Co - Key Facts 10
Becton Dickinson and Co - Major Products and Services 11
Becton Dickinson and Co Pipeline Products by Development Stage 14
Becton Dickinson and Co Ongoing Clinical Trials by Trial Status 17
Becton Dickinson and Co Pipeline Products Overview 19
BD FACSClearCount CD4 Analyzer 19
BD FACSClearCount CD4 Analyzer Product Overview 19
BD FlowSmart Infusion Set 20
BD FlowSmart Infusion Set Product Overview 20
BD Libertas Patch Injector 21
BD Libertas Patch Injector Product Overview 21
BD MAX - Enteric Viral 22
BD MAX - Enteric Viral Product Overview 22
BD Max - Extended Enteric Bacterial Panel 23
BD Max - Extended Enteric Bacterial Panel Product Overview 23
BD Max BK Assay 24
BD Max BK Assay Product Overview 24
BD Max CMV Assay 25
BD Max CMV Assay Product Overview 25
BD Max HPV Assay 26
BD Max HPV Assay Product Overview 26
BD Max Next Gen MRSA Assay 27
BD Max Next Gen MRSA Assay Product Overview 27
BD MAX Next Generation CRO Assay 28
BD MAX Next Generation CRO Assay Product Overview 28
BD Max TB Assay 29
BD Max TB Assay Product Overview 29
BD MAX VanR Assay 30
BD MAX VanR Assay Product Overview 30
BD Onclarity HPV Assay 31
BD Onclarity HPV Assay Product Overview 31
BD Phoenix - Dual AST Panel 32
BD Phoenix - Dual AST Panel Product Overview 32
BD Phoenix Yeast ID Panel 33
BD Phoenix Yeast ID Panel Product Overview 33
BD Posiflush Heparin Lock Flush Syringe 34
BD Posiflush Heparin Lock Flush Syringe Product Overview 34
BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride 35
BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride Product Overview 35
BD SurePath Plus Molecular Pap Test System 36
BD SurePath Plus Molecular Pap Test System Product Overview 36
BD Veritor Adenovirus Assay 37
BD Veritor Adenovirus Assay Product Overview 37
BD Viper LT HSV 1/2 Assay 38
BD Viper LT HSV 1/2 Assay Product Overview 38
BD Viper LT System - CT/GC Assay 39
BD Viper LT System - CT/GC Assay Product Overview 39
BD Viper LT System - HPV 40
BD Viper LT System - HPV Product Overview 40
BD Viper LT System - HPV Clinical Trial 41
BD Viper LT Trichomonas Assay 42
BD Viper LT Trichomonas Assay Product Overview 42
Biomarker Panel - Sepsis 43
Biomarker Panel - Sepsis Product Overview 43
Biomarker-Cervical Cancer 44
Biomarker-Cervical Cancer Product Overview 44
Diagnostic Test - Breast Cancer 45
Diagnostic Test - Breast Cancer Product Overview 45
Diagnostic Test - Ovarian Cancer 46
Diagnostic Test - Ovarian Cancer Product Overview 46
DNA - Molecule Counter 47
DNA - Molecule Counter Product Overview 47
Dx Mini 48
Dx Mini Product Overview 48
Dx Pro 49
Dx Pro Product Overview 49
Extended Wear Insulin Infusion Set 50
Extended Wear Insulin Infusion Set Product Overview 50
Genesis Low Temperature Rigid Sterilization Container System 51
Genesis Low Temperature Rigid Sterilization Container System Product Overview 51
Jaguar GBS Assay 52
Jaguar GBS Assay Product Overview 52
MRSA/SA Assay 53
MRSA/SA Assay Product Overview 53
Next Generation Pen Needle II 54
Next Generation Pen Needle II Product Overview 54
Odon Device 55
Odon Device Product Overview 55
Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever 56
Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever Product Overview 56
Sepsis Flow Cytometric Diagnostic System 57
Sepsis Flow Cytometric Diagnostic System Product Overview 57
Becton Dickinson and Co - Key Competitors 58
Becton Dickinson and Co - Key Employees 59
Becton Dickinson and Co - Key Employee Biographies 61
Becton Dickinson and Co - Locations And Subsidiaries 62
Head Office 62
Other Locations & Subsidiaries 62
Recent Developments 69
Becton Dickinson and Co, Recent Developments 69
Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 69
Mar 21, 2017: Retractable Technologies Announces Litigation Updates 69
Mar 01, 2017: Pyxis ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care 69
Feb 22, 2017: BD Veritor System Meets FDAs New Performance Requirements For Rapid Influenza Antigen Detection Tests 70
Feb 20, 2017: BD Demonstrates Synchronized Technology Platform at HIMSS17 70
Feb 13, 2017: BD Announces Early Access Program for BD Resolve Single-Cell Analysis Platform 71
Feb 10, 2017: CareFusion Recalls Alaris Pump Module due to an Alarm Error Which May Cause Interruption of Therapy 72
Jan 23, 2017: PleurX Catheter System Receives FDA 510(k) Clearance For Specific Non-Malignant Recurrent Pleural Effusions 73
Dec 15, 2016: BD Launches Advanced Prefillable Syringe For Higher Volume Injection Of Biologics 73
Dec 05, 2016: BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management 74
Appendix 75
Methodology 75
About GlobalData 77
Contact Us 77
Disclaimer 77

List Of Tables

Becton Dickinson and Co Pipeline Products and Ongoing Clinical Trials Overview 7
Becton Dickinson and Co Pipeline Products by Equipment Type 8
Becton Dickinson and Co Pipeline Products by Indication 9
Becton Dickinson and Co Ongoing Clinical Trials by Trial Status 9
Becton Dickinson and Co, Key Facts 10
Becton Dickinson and Co, Major Products and Services 11
Becton Dickinson and Co Number of Pipeline Products by Development Stage 14
Becton Dickinson and Co Pipeline Products Summary by Development Stage 15
Becton Dickinson and Co Ongoing Clinical Trials by Trial Status 17
Becton Dickinson and Co Ongoing Clinical Trials Summary 18
BD FACSClearCount CD4 Analyzer - Product Status 19
BD FACSClearCount CD4 Analyzer - Product Description 19
BD FlowSmart Infusion Set - Product Status 20
BD FlowSmart Infusion Set - Product Description 20
BD Libertas Patch Injector - Product Status 21
BD Libertas Patch Injector - Product Description 21
BD MAX - Enteric Viral - Product Status 22
BD MAX - Enteric Viral - Product Description 22
BD Max - Extended Enteric Bacterial Panel - Product Status 23
BD Max - Extended Enteric Bacterial Panel - Product Description 23
BD Max BK Assay - Product Status 24
BD Max BK Assay - Product Description 24
BD Max CMV Assay - Product Status 25
BD Max CMV Assay - Product Description 25
BD Max HPV Assay - Product Status 26
BD Max HPV Assay - Product Description 26
BD Max Next Gen MRSA Assay - Product Status 27
BD Max Next Gen MRSA Assay - Product Description 27
BD MAX Next Generation CRO Assay - Product Status 28
BD MAX Next Generation CRO Assay - Product Description 28
BD Max TB Assay - Product Status 29
BD Max TB Assay - Product Description 29
BD MAX VanR Assay - Product Status 30
BD MAX VanR Assay - Product Description 30
BD Onclarity HPV Assay - Product Status 31
BD Onclarity HPV Assay - Product Description 31
BD Phoenix - Dual AST Panel - Product Status 32
BD Phoenix - Dual AST Panel - Product Description 32
BD Phoenix Yeast ID Panel - Product Status 33
BD Phoenix Yeast ID Panel - Product Description 33
BD Posiflush Heparin Lock Flush Syringe - Product Status 34
BD Posiflush Heparin Lock Flush Syringe - Product Description 34
BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride - Product Status 35
BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride - Product Description 35
BD SurePath Plus Molecular Pap Test System - Product Status 36
BD SurePath Plus Molecular Pap Test System - Product Description 36
BD Veritor Adenovirus Assay - Product Status 37
BD Veritor Adenovirus Assay - Product Description 37
BD Viper LT HSV 1/2 Assay - Product Status 38
BD Viper LT HSV 1/2 Assay - Product Description 38
BD Viper LT System - CT/GC Assay - Product Status 39
BD Viper LT System - CT/GC Assay - Product Description 39
BD Viper LT System - HPV - Product Status 40
BD Viper LT System - HPV - Product Description 40
BD Viper LT System - HPV - Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System with Cervical Specimens 41
BD Viper LT Trichomonas Assay - Product Status 42
BD Viper LT Trichomonas Assay - Product Description 42
Biomarker Panel - Sepsis - Product Status 43
Biomarker Panel - Sepsis - Product Description 43
Biomarker-Cervical Cancer - Product Status 44
Biomarker-Cervical Cancer - Product Description 44
Diagnostic Test - Breast Cancer - Product Status 45
Diagnostic Test - Breast Cancer - Product Description 45
Diagnostic Test - Ovarian Cancer - Product Status 46
Diagnostic Test - Ovarian Cancer - Product Description 46
DNA - Molecule Counter - Product Status 47
DNA - Molecule Counter - Product Description 47
Dx Mini - Product Status 48
Dx Mini - Product Description 48
Dx Pro - Product Status 49
Dx Pro - Product Description 49
Extended Wear Insulin Infusion Set - Product Status 50
Extended Wear Insulin Infusion Set - Product Description 50
Genesis Low Temperature Rigid Sterilization Container System - Product Status 51
Genesis Low Temperature Rigid Sterilization Container System - Product Description 51
Jaguar GBS Assay - Product Status 52
Jaguar GBS Assay - Product Description 52
MRSA/SA Assay - Product Status 53
MRSA/SA Assay - Product Description 53
Next Generation Pen Needle II - Product Status 54
Next Generation Pen Needle II - Product Description 54
Odon Device - Product Status 55
Odon Device - Product Description 55
Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever - Product Status 56
Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever - Product Description 56
Sepsis Flow Cytometric Diagnostic System - Product Status 57
Sepsis Flow Cytometric Diagnostic System - Product Description 57
Becton Dickinson and Co, Key Employees 59
Becton Dickinson and Co, Key Employee Biographies 61
Becton Dickinson and Co, Other Locations 62
Becton Dickinson and Co, Subsidiaries 63
Glossary 76

List Of Figures

Becton Dickinson and Co Pipeline Products by Equipment Type 8
Becton Dickinson and Co Pipeline Products by Development Stage 14
Becton Dickinson and Co Ongoing Clinical Trials by Trial Status 17

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available